DOLPAC MEDIUM DOGS TABLETS
DOLPAC MEDIUM DOGS TABLETS
Authorised
- Oxantel pamoate
- Praziquantel
- Pyrantel embonate
Product identification
Medicine name:
DOLPAC MEDIUM DOGS TABLETS
Dolpac Vet
Active substance:
- Oxantel pamoate
- Praziquantel
- Pyrantel embonate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxantel pamoate559.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
Finland
Package description:
- Cardboard box with 1 strip of 3 tablets
- Cardboard box with 10 strips of 6 tablets
- Cardboard box with 5 strips of 6 tablets
- Cardboard box with 3 strips of 6 tablets
- Cardboard box with 1 strip of 6 tablets
- Cardboard box with 20 strips of 3 tablets
- Cardboard box with 10 strips of 3 tablets
- Cardboard box with 6 strips of 3 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 23470
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0183/002
Concerned member states:
-
Austria
-
Cyprus
-
Czechia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 13/06/2025